Beacon Biosignals has raised $97m to advance development of its electroencephalogram (EEG) recording technology in areas including precision medicine and diagnostics. The company’s Series B extension ...
BOSTON, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Beacon Biosignals, the global leader in at-home EEG and AI-powered brain health analytics, presented two scientific posters at the American Epilepsy Society ...
BOSTON and SAN DIEGO, July 24, 2024 (GLOBE NEWSWIRE) -- Beacon Biosignals, a leader in at-home sleep monitoring and computational neurodiagnostics, today announced a strategic collaboration with Skye ...
The MarketWatch News Department was not involved in the creation of this content. BOSTON, April 06, 2026 (GLOBE NEWSWIRE) -- Beacon Biosignals today announced an extension to its Series B financing, ...
Beacon Biosignals, known for its sleep monitoring system, hauled in $86 million as part of an oversubscribed series B funding round that will be used to develop a new neurodiagnostic data set. The ...